– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in...
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical...
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory...
Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty DayCAMBRIDGE,...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
Dual Recognition Underscores Therabody's Leadership in Driving the Future of Wellness with Science-Backed, Clinically Proven Innovations LOS ANGELES, Oct. 9,...
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 9,...
SHORT HILLS, N.J., Oct. 9, 2025 /PRNewswire/ -- Doceree, the only AI-powered Operating System for healthcare marketing, today announced the integration...
BOSTON, Oct. 9, 2025 /PRNewswire/ -- Today, Outcomes4Me announced it has been named to TIME's Best Inventions of 2025 list....
TIME Best Inventions honors extraordinary innovations changing lives DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader...
Fuzzball enables FYR's EV-Omics platform to process complex data at production scale to create reproducible, high-quality analytical pipelines in hours,...
Cognivia Signal expected to reduce trial dropout risk and placebo impact for pharma and biotech trial sponsors. MONT-SAINT-GUIBERT, Belgium, Oct....
BOSTON, Oct. 9, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science...
Calgary, Alberta--(Newsfile Corp. - October 9, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
Calgary, Alberta--(Newsfile Corp. - October 9, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
NAPLES, FL / ACCESS Newswire / October 9, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell...
NAPLES, FL / ACCESS Newswire / October 9, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell...
Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global...
Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global...
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the...